Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-11-009134
Filing Date
2011-02-04
Accepted
2011-02-04 13:10:31
Documents
1
Group Members
ARNOLD L. ORONSKYBRUCE A. CLEVELANDCHRISTOPHER B. EHRLICHDOUGLAS A. PEPPERGILBERT H. KLIMANHARVEY B. CASHINTERWEST MANAGEMENT PARTNERS IX, LLCKHALED A. NASRLINDA S. GRAISMICHAEL B. SWEENEYNINA S. KJELLSONPHILIP T. GIANOSTHOMAS L. ROSCHW. STEPHEN HOLMES II

Document Format Files

Seq Description Document Type Size
1 SC 13G/A f58039asc13gza.htm SC 13G/A 233424
  Complete submission text file 0000950123-11-009134.txt   236043
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 11573626
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

EIN.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A